๐Ÿ”ฎForecastHer
๐ŸŒฟ WellnessTrading

Will microdosing GLP-1 drugs gain widespread use for PCOS management by end of 2026?

Current Probability

55%

308 days left

$9,870 volume

55% Yes45% No
About This Market

Tracks whether GLP-1 receptor agonists become commonly recommended for PCOS management.

Resolution Criteria

At least two major health systems or professional organizations recommend GLP-1 for PCOS management.

Closes: Thursday, December 31, 2026
Trade
Market Stats
Total Volume$9,870
Liquidity100
CreatedFeb 25
Will microdosing GLP-1 drugs gain widespread use for PCOS management by end of 2026? | ForecastHer